If you liked this article you might like

Regeneron, Sanofi Score Eczema Drug Approval
Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer
XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO